Firms

Relyens Innovation Sante

Lyon, France

relyens.eu

turennecapital.com

api-avis-situation-sirene.insee.fr

bodacc.fr

Relyens Innovation Santé (formerly SHAM Innovation Santé) is the dedicated healthcare corporate venture investment vehicle of the European mutual insurance group Relyens. The active French SAS, SIREN 801985995, operates as a société de capital risque (SCR) and is advised by Turenne Santé, the healthcare division of Turenne Groupe, since its 2014 launch. The corporate investing vehicle is distinct from its insurer parent and its external adviser; a named Relyens investment does not create a second Turenne cash investment. It backs disruptive biotechnology, medical devices, diagnostics and digital-health technologies addressing substantial unmet needs, including neuroscience and AI-enabled drug discovery. Its own public portfolio names DeepLife, Carthera, BrainEver and Coave among 17 current companies. Its stated initial equity range is EUR 0.5–3M, with cumulative investment up to EUR 7M per company; these ranges are not actual disclosed tickets. The own page reports over EUR 60M invested and 10 exits, which are cumulative activity metrics rather than a closed LP fund. Its public branding is the shared Relyens mark, verified on the dedicated vehicle page and on a vehicle-specific Kimialys financing release. Sandrine Pernette provides Relyens investment oversight, while Edwige Rossignol and Benjamin Reydellet are the latest official named directeurs généraux; Claire Poulard’s role is qualified as an external Turenne adviser. Parent insurance staff and all unrelated Turenne division staff are not imported as vehicle employees.

Founded: 2014
Type: Venture capital

Funds1

Relyens Innovation Sante (formerly SHAM Innovation Sante) corporate SCR vehicle——
Named corporate SCR investment vehicle established in2014 and advised by Turenne Santé. No independently verified third-party LP close; corporate share capital and cumulative deployed capital excluded.

Team

Operations and support

Benjamin ReydelletDirecteur général

Claire PoulardTurenne Santé investment director advising the vehicle

Edwige RossignolDirecteur général

Sandrine PernetteRelyens investment director overseeing Innovation Santé

Co-investing

Beiersdorf AG

DeepLife$10M · 2024-12-16

Groupe Prunay

DeepLife$10M · 2024-12-16

Panakès Partners

Carthera$— · Unknown date

YZR Capital

DeepLife$10M · 2024-12-16

Investments

$10M2024-12-16	DeepLife	YZR Capital, Relyens Innovation Sante, Groupe Prunay, Beiersdorf AG
$—Unknown date	Carthera	Panakès Partners, Relyens Innovation Sante

team@apexlogos.ai19 hours ago
Reviewed 8 October 2026. Relyens Innovation Santé is the exact active corporate SCR investment vehicle SIREN 801985995, formerly SHAM Innovation Santé. Its insurer parent and adviser Turenne Santé are separate entities; the vehicle is the named DeepLife buyer. Four public people are attached with executive, investment-oversight or external-adviser qualifications. Corporate Relyens branding is verified directly on the dedicated vehicle page and a vehicle-specific issuer financing release. No private LP close is verified: statutory share capital EUR40,012,000, cumulative capital invested and parent insurer investment assets are not fundraise amounts. One named corporate vehicle is recorded with amount and exact launch day NULL. DeepLife financing callback is owned by batch581. Other primary portfolio entries require issuer-level legal and round audits; no bare companies created.